The role of the PI3K/AKT/mTOR pathway in ovarian cancer is extremely complex, arising from two main sources: (1) the diverse alterations found with PI3K/AKT/mTOR pathway itself; and (2) the diverse alterations in inputs into the PI3K/AKT/mTOR pathway. Here, AKT1 is linked to ovarian cancer.